If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep ...
View all of Acadian’s mutual funds and start searching ... further sorted by data points such as Morningstar Ratings, Total Return Rankings, Fee Level Rating and Morningstar Category.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company with a market capitalization of $3.06 billion, focuses on developing and commercializing innovative medicines to address unmet ...
TD Cowen analyst Ritu Baral maintained a Buy rating on ACADIA Pharmaceuticals (ACAD – Research Report) today and set a price target of $35.00.
RBC Capital analyst Kenneth Lee maintained a Hold rating on Acadian Asset Management (AAMI – Research Report) yesterday and set a price target ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results